Gamma-hydroxybutyrate (Acide gamma-hydroxybutyrique) (Powder)

$200.00$900.00

Because of sodium oxybate’s history of abuse as a recreational drug, the FDA approved it as a Schedule III Controlled Substance. A limited distribution program that includes physician education, patient education, a patient and physician registry, and detailed patient surveillance has been established. Under the program, prescribers and patients are able to obtain the product only through a single centralized pharmacy.

Recent studies have shown a decrease in the incidence of GHB intoxications. Public health measures to inform young people of the risks of GHB and governmental restrictions on the sale of GHB and its precursors (GBL and 1,4-butanediol [1,4-BD]) have been helpful in promoting this decrease.